India Point-of-Care Arterial Blood Gas Monitoring Devices Market - 2025-2033

The India point-of-care arterial blood gas monitoring devices market reached US$ 73.16 million in 2024 and is expected to reach US$ 137.46 million by 2033, growing at a CAGR of 7.3% during the forecast period of 2025-2033.

Point-of-care arterial blood gas (ABG) monitoring devices are medical devices used for the rapid measurement and analysis of arterial blood gases at the patient's bedside or near the point of care rather than in a central laboratory. These devices are designed to provide immediate feedback on critical parameters, including oxygen and carbon dioxide levels, pH, bicarbonate, and oxygen saturation, among others.

By offering real-time results, they help healthcare providers make timely decisions for managing patients with respiratory or metabolic issues, such as those in intensive care units, in emergency departments, or during surgical procedures. Point-of-care ABG devices typically feature compact, user-friendly designs that require minimal technical expertise to operate and offer faster results compared to traditional laboratory testing methods.

Market Dynamics: Drivers & Restraints

Growing Incidence of Chronic Diseases

The growing incidence of chronic diseases in India, particularly respiratory conditions like chronic obstructive pulmonary disease (COPD), asthma, and cardiovascular disorders, is significantly driving the demand for Point-of-Care Arterial Blood Gas (ABG) monitoring devices.

For instance, according to a modeling study, the global prevalence of COPD is projected to reach nearly 600 million cases by 2050, reflecting a 23% increase in the number of individuals affected by the condition compared to 2020. Chronic diseases often require regular monitoring of blood gases such as oxygen, carbon dioxide, and pH levels to manage the condition effectively. This increase in the number of chronic diseases increases the demand for point-of-care arterial blood gas monitoring devices, as patients seek advanced, portable devices.

Conventionally, these tests were performed in centralized labs, which required patients to visit healthcare facilities and wait for results. However, with the increasing prevalence of these conditions and the shift toward more patient-centric healthcare, there is a growing need for rapid, real-time diagnostic tools that can be used outside hospital settings. Point-of-care ABG devices provide this solution by enabling healthcare professionals to quickly assess and monitor a patient's condition at the bedside or in home care settings. This ease of access and the ability to make faster clinical decisions are essential in managing chronic diseases, thus driving the adoption of these devices in India.

Accessibility and Cost Barriers

Accessibility and cost barriers can pose significant restraints to the widespread adoption of Point-of-Care Arterial Blood Gas (ABG) monitoring devices in India. While these devices offer convenience and faster diagnosis, their high upfront cost can limit their availability, especially in rural or economically disadvantaged regions. Smaller healthcare centers or clinics with limited budgets may struggle to afford these advanced diagnostic tools, opting instead for traditional, more affordable methods that are slower and less efficient.

Segment Analysis

The India point-of-care arterial blood gas monitoring devices market is segmented based on the product type, modality, and end-users.

Consumables in the product type segment are expected to dominate the point-of-care arterial blood gas monitoring devices market

Consumables in the product type segment are expected to dominate the point-of-care arterial blood gas (ABG) monitoring devices market due to their essential role in the ongoing operation of these devices. Consumables, such as blood gas cartridges, sensors, and calibration solutions, are integral to performing accurate tests and ensuring the longevity and reliability of the monitoring devices.

As point-of-care ABG devices become more widely adopted in hospitals, clinics, and even home care settings, the demand for these consumables is expected to rise steadily. Additionally, consumables are critical for maintaining the accuracy and precision of test results, which is crucial for managing patients with chronic conditions like respiratory and cardiovascular diseases. The need for regular, consistent monitoring in such conditions further reinforces the dominance of consumables in the market, as they are a key component in ensuring optimal device performance and patient care.

Competitive Landscape

The market players in the point-of-care arterial blood gas monitoring devices market are Radiometer India, Abbott, Siemens Healthcare Private Limited, EDAN Instruments, Inc., OPTI Medical Systems, Werfen, F. Hoffmann-La Roche Ltd, and Wondfo, among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
• Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The India point-of-care arterial blood gas monitoring devices market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

• Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.